Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2852409

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.5.2013
  • EP published:
    25.3.2020
  • EP application number:
    13729591.1
  • Max expiry date:
    20.5.2033
  • Title:
    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

Timeline

Today
21.5.2013EP application
25.3.2020EP Publication

Owner

  • Name:
    Astellas Pharma Inc.
  • Address:
    5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
  • Name:
    TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
  • Address:
    Freiligrathstrasse 12, 55131 Mainz, DE

Inventor

  • Name:
    SAHIN, Ugur
  • Address:
    55116 Mainz, DE
  • Name:
    TÜRECI, Özlem
  • Address:
    55116 Mainz, DE
  • Name:
    MITNACHT-KRAUS, Rita
  • Address:
    61169 Friedberg, DE
  • Name:
    JACOBS, Stefan Denis
  • Address:
    55252 Mainz-Kastel, DE
  • Name:
    UTSCH, Magdalena Jadwiga
  • Address:
    55262 Heidesheim am Rhein, DE
  • Name:
    HEINZ, Cornelia Adriana Maria
  • Address:
    55278 Dalheim, DE
  • Name:
    STADLER, Christiane Regina
  • Address:
    64625 Bensheim, DE

Priority

  • Number:
    PCT/EP2012/002211
  • Date:
    23.5.2012
  • Country:
    WO

Classification

  • Categories:
    A61K 39/395, C07K 16/30, A61K 45/06

Upload documents